Myocarditis risk from Covid-19 is 4x higher than from BNT162b2 mRNA vaccine. https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 https://www.nejm.org/doi/full/

Myocarditis risk from Covid-19 is 4x higher than from BNT162b2 mRNA vaccine. https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 Vaccination was most strongly associated with an elevated risk of myocarditis (risk ratio, 3.24; 95% confidence interval [CI], 1.55 to 12.44; risk difference, 2.7 events per 100,000 persons; 95% CI, 1.0 to 4.6) SARS-CoV-2 infection was associated with a substantially increased risk of myocarditis (risk ratio, 18.28; 95% CI, 3.95 to 25.12; risk difference, 11.0 events per 100,000 persons; 95% CI, 5.6 to 15.8)